Last updated on June 2020

A Study of MORAb-202 in Participants With Solid Tumors


Brief description of study

The primary objective of this study is to evaluate the tolerability and safety profile of MORAb-202 in participants with solid tumors.

Clinical Study Identifier: NCT03386942

Find a site near you

Start Over